T-PLL-1 protocol of the German CLL study group (GCLLSG) - A prospective phase II trial of fludarabine phosphate, mitoxantrone and cyclophosphamide (FMC) followed by alemtuzumab consolidation in T-PLL.
Journal title abbreviation:
Blood
Year:
2005
Journal volume:
106
Journal issue:
11
Pages contribution:
602A-603A
Language:
eng
Print-ISSN:
0006-4971
TUM Institution:
Institut für Medizinische Statistik und Epidemiologie